📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Challenges of phase III trial design for novel treatments in diseases with no standard treatment: The AZA-001 myelodysplasia study model (2014)

First Author: Fenaux P

Attributed to: MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.leukres.2013.10.014

PubMed Identifier: 24360612

Publication URI: http://europepmc.org/abstract/MED/24360612

Type: Journal Article/Review

Parent Publication: Leukemia Research

Issue: 2

ISSN: 0145-2126